Corneal Endothelial Cell Loss and Iritis Associated With a New Cosmetic Iris Implant

JAMA Ophthalmol. 2015 Jun;133(6):723-4. doi: 10.1001/jamaophthalmol.2015.0488.

Authors

Alla Kelly¹, Stephen C Kaufman²

Affiliations

¹ St Paul Eye Clinic, St Paul, Minnesota2Department of Ophthalmology and Visual Neurosciences, University of Minnesota, St Paul.
² Department of Ophthalmology and Visual Neurosciences, University of Minnesota, St Paul3Department of Ophthalmology, State University of New York Downstate, Brooklyn.

PMID: 25811391
DOI: 10.1001/jamaophthalmol.2015.0488

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Anti-Bacterial Agents / therapeutic use
Antihypertensive Agents / therapeutic use
Corneal Endothelial Cell Loss / diagnosis
Corneal Endothelial Cell Loss / etiology*
Corneal Endothelial Cell Loss / therapy
Cosmetic Techniques / instrumentation*
Device Removal
Female
Glucocorticoids / therapeutic use
Humans
Iris*
Iritis / diagnosis
Iritis / etiology*
Iritis / therapy
Prostheses and Implants / adverse effects*
Tomography, Optical Coherence

Substances

Anti-Bacterial Agents
Antihypertensive Agents
Glucocorticoids